Science Explorer Interactive view Map
Nonprofit · Paris · France

Arcagy Gineco

arcagy.org/arcagy-gineco-organisation-et-rechercheROR OpenAlex
Research works
42
▲ 159% vs 2013–17
Citations
459
11.0 per fractional work
Top-10% rate
22.6%
record average 16.5%
Open access
38%
world 28%

Not ranked overall: Arcagy Gineco is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.93× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 1.11× its world share, 0 worksImmunology and Micro…Neuroscience: 0.09× its world share, 0 worksNeuroscienceComputer Science: 0.07× its world share, 0 worksComputer ScienceEngineering: 0.05× its world share, 0 worksEngineeringMathematics: 0.29× its world share, 0 worksMathematicsMedicine: 3.79× its world share, 7 worksMedicineDecision Sciences: 0.87× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.00× its world share, 0 worksEconomics, Econometr…Psychology: 0.10× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 3.9×. Every wedge is a field page.

Which keywords describe research at Arcagy Gineco?

By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Clinical Trials, Biomarkers, Ovarian Cancer, Metastasis, Cytoreductive Surgery, Genomic Analysis and Mutation Analysis.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy10▲ 35×18 topics
  2. Clinical Trials8▲ 31×6 topics
  3. Biomarkers8▲ 30×5 topics
  4. Ovarian Cancer8▲ 195×2 topics
  5. Metastasis7▲ 52×5 topics
  6. Cytoreductive Surgery7▲ 269×2 topics
  7. Genomic Analysis7▲ 54×2 topics
  8. Mutation Analysis6▲ 210×1 topic
  9. Tumor Models6▲ 257×1 topic
  10. Breast Cancer4▲ 36×7 topics
  11. Cancer Therapy4▲ 15×6 topics
  12. Survival Analysis4▲ 33×6 topics
  13. Homologous Recombination4▲ 124×2 topics
  14. Cell Death3▲ 39×2 topics
  15. Synthetic Lethality3▲ 322×2 topics
  16. BRCA Mutation3▲ 461×1 topic
  17. PARP Inhibitors3▲ 461×1 topic
  18. Clinical Practice Guidelines3▲ 13×6 topics
  19. Metastatic Breast Cancer3▲ 111×2 topics
  20. Quality of Life3▲ 5.6×5 topics
  21. Cervical Cancer2▲ 56×2 topics
  22. Immunotherapy2▲ 8.5×11 topics
  23. Molecular Classification2▲ 36×2 topics
  24. Chemotherapy-Induced Peripheral Neuropathy2▲ 95×1 topic
  25. Radiation Therapy2▲ 32×2 topics
  26. Targeted Therapy2▲ 22×5 topics
  27. Taxanes2▲ 95×1 topic
  28. Brachytherapy2▲ 123×1 topic
  29. Endometrial Carcinoma2▲ 123×1 topic
  30. Sentinel Lymph Node Biopsy2▲ 66×2 topics
  31. Metastatic2▲ 69×2 topics
  32. Trastuzumab2▲ 88×2 topics
  33. EGFR2▲ 121×1 topic
  34. HER22▲ 121×1 topic
  35. Precision Medicine2▲ 12×3 topics
  36. Colorectal Cancer1▲ 30×2 topics
  37. Radiotherapy1▲ 7.8×6 topics
  38. CDK4/6 Inhibitors1▲ 163×1 topic
  39. Molecular Subtypes1▲ 30×2 topics
  40. Palbociclib1▲ 163×1 topic

Which research topics does Arcagy Gineco publish most on?

By volume in 2022–2025: Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, Endometrial and Cervical Cancer Treatments and BRCA gene mutations in cancer.

Ovarian cancer diagnosis…2Ovarian cancer diagnosis and treatment: 2 fractional worksPARP inhibition in cance…2PARP inhibition in cancer therapy: 2 fractional worksEndometrial and Cervical Cancer Treatments: 1 fractional worksBRCA gene mutations in cancer: 0 fractional worksProstate Cancer Treatmen…0Prostate Cancer Treatment and Research: 0 fractional worksBreast Cancer Treatment Studies: 0 fractional worksCancer Genomics and Diagnostics: 0 fractional worksCancer Research and Treatments: 0 fractional worksEconomic and Financial Impacts of Cancer: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional works
Reproductive MedicineOncologyObstetrics and GynecologyGenetics4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Ovarian cancer diagnosis and treatment Reproductive Medicine 2 works
  2. 2 PARP inhibition in cancer therapy Oncology 2 works
  3. 3 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 1 works
  4. 4 BRCA gene mutations in cancer Genetics 0 works
  5. 5 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 0 works
  6. 6 Breast Cancer Treatment Studies Cancer Research 0 works
  7. 7 Cancer Genomics and Diagnostics Cancer Research 0 works
  8. 8 Cancer Research and Treatments Biotechnology 0 works
  9. 9 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
  10. 10 Cancer Immunotherapy and Biomarkers Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available38.0%not open62.0%

World: 28% of research is openly available.

with international co-authors46.3%domestic only53.7%

World: 19% is written across borders.

How has Arcagy Gineco's research output changed?

Output in 2018–2022 was 159% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Paris

All research institutions in Paris

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.